Oxbryta (voxelotor) is a brand-name drug that’s prescribed for sickle cell disease in adults and certain children. As with other drugs, Oxbryta can cause side effects, such as headache, abdominal pain ...

Hydroxyurea was used in a 25-year-old man with SCD who had AP and recurrent SP. [21] The patient had received hydralazine, piracetam, and pentoxifylline, but the AP and SP episodes continued over the ...

Large European cohort data suggest hydroxyurea pregnancy exposure in sickle cell disease is not linked to congenital ...

In female patients living with sickle cell disease (SCD), hydroxyurea had no effect on ovarian reserve, suggesting that fertility preservation measures prior to treatment may be unnecessary, according ...